BreStem Therapeutics, Inc.

Biotechnology company · Raleigh, North Carolina, United States

BreStem Therapeutics, Inc. is a biotechnology company headquartered in Raleigh, North Carolina, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

BreStem Therapeutics at a glance

Typebiotechnology company

HeadquartersRaleigh, North Carolina, United States

Earliest incorporation on record2017

SEC CIK1723963

What does BreStem Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $3 million sold (2021).

Frequently asked questions about BreStem Therapeutics

Where is BreStem Therapeutics headquartered?

BreStem Therapeutics, Inc. is headquartered in Raleigh, North Carolina, United States.

What does BreStem Therapeutics do?

BreStem Therapeutics, Inc. is a biotechnology company.

When was BreStem Therapeutics founded?

The earliest incorporation on record for BreStem Therapeutics, Inc. is in 2017, according to public company registers.

Similar companies

Arrevus, Inc.Raleigh, North Carolina, United States
NuPulseCV, Inc.Raleigh, North Carolina, United States
GeneVentiv Therapeutics, Inc.Raleigh, North Carolina, United States
RainBio, Inc.Raleigh, North Carolina, United States
Aer Therapeutics, Inc.Raleigh, North Carolina, United States
Merz Pharmaceuticals, LLCRaleigh, North Carolina, United States
Glycan Therapeutics CorporationRaleigh, North Carolina, United States
Tribofilm Research IncRaleigh, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences